Houston Voices

3 personality traits every entrepreneur has, according to the University of Houston

There are many character traits a startup founder needs to ensure success. You have to be a hard worker with communications skills and charisma and…so much more. Miguel Tovar/University of Houston

It's no secret that every successful business leader has multiple personality traits.

It seems everyone has a fantasy about starting a business. "I'd open up a record store." "I'd sell my famous meatball sandwiches my family loves so much." "I would totally own a comic book shop."

In fact, according to the University of Phoenix, over 60 percent of 20+ year-olds have strongly considered starting their own business.

I mean, that's a step in the right direction. You have to have desire. We can all agree there. But surely it takes more than that if you're serious about starting, and maintaining, a business, right?

So, here we'll take a look three personality traits just about every startup founder possesses.

The ability to look forward

Vision. Imagine walking everywhere with a cap brim so low over your eyes, that you can only see your feet when you walk. You can't see anything beyond that. You cannot see the cars, mailboxes, pedestrians, trees, or anything that might come your way. That's what it's like if you don't have vision.

Without a vision for the future, for what lies beyond, you will not be prepared for the inevitable obstacles. You won't know when to change direction. When brace yourself for a coming problem and prepare for it. You need to look beyond the present and envision what your company will look like in 10 years. And then persuade others to see that same vision and invest in it.

Communication

Communication. There's a video on YouTube of a dog running down a sidewalk in a small town barking at two police officers. The cops could tell by the dog's movements and tone that he was barking not out of aggression, but because he needed something. The policemen followed the dog and discovered a burning house with children inside. Thankfully, they managed to save the kids as the house burned to cinders.

Despite the obvious interspecies communication barrier, the dog was able to communicate that something was wrong so that this problem could be solved. Far too often, a young startup founder will identify a big problem or a big need and spark a great idea for how to solve it, only to discover they aren't very good at communicating the problem and solution to investors. If you cannot communicate the problem, solution, and why you're the right man or woman for carrying out the solution, you'll have a hard time convincing investors to part with their money.

The best way to improve your communication skills is baptism by fire. Go out and, well, communicate! Do it often and soon you'll learn the nuances and intricacies of effective communication. Hand gestures, head movement, tone and timber, reading the other person, etc.

Persistence 

Persistence. You're going to encounter obstacles. I know, breaking news, right? You'll hit a snag here or there. Someone won't like your idea. An investor will pull out. Something. But because you're serious about making it, you have to just pull your collar up and face the cold winter wind. Keep marching forward. However, there's something I like to call "intelligent persistence."

Let's say someone doesn't like an idea you have. Maybe they don't think it's wise to add a flap to your what-cha-ma-whos-it contraption. Persistence doesn't mean don't listen to them and persist anyway. No. Intelligent persistence is listening to them, making a decision based on the feedback, and persisting with a more intelligent direction in mind. You have to listen to feedback, both the good and the bad. Persistence doesn't mean to ignore the bad. It means listen, get enlightened, and make a more educated decision in moving forward. Don't let the bad stuff drag you down. But don't go forward without learning from your negative feedback either.

------

This article originally appeared on the University of Houston's The Big Idea.

Rene Cantu is the writer and editor at UH Division of Research.

Trending News

Building Houston

 
 

The Texas Medical Center Innovation Factory has named the 16 companies making up the inaugural cohort in the Innovate UK Global Incubator Programme. Photo via tmc.edu

Sixteen digital health and medical device startups founded in the United Kingdom have been selected for a customized accelerator at the Texas Medical Center's Innovation Factory.

In partnership with Innovate UK, TMCi created the Innovate UK Global Incubator Programme, a new accelerator that supports UK businesses as they build their United States go-to-market plan. The program builds the BioBridge relationship between TMC and the UK that was originally established five years ago.

“The TMC UK BioBridge program was launched with the UK Department for Business and Trade in 2018 to serve as a gateway for advancing life sciences and foster innovation and research between our two countries," says Ashley McPhail, chief external affairs and administration officer for TMC, in a news release. "We saw an opportunity to work with Innovate UK to develop a larger program with the UK after the success of the 11 companies that previously participated in our health tech accelerator."

The 16 companies will participate in the program from June to November. The cohort is expected to arrive in Houston on June 5 and have access to TMCi's facilities, network of mentors and potential clients, funding, potential customers, and curated programing — all while being a unique entry point into the US. The new offering joins three other globally recognized curriculums: Biodesign, Accelerator for Cancer Therapeutics, and Health Tech.

“TMCi nurtures long-term growth, development, and competitiveness to increase startups chances of success and global expansion," says Emily Reiser, associate director of TMC Innovation. "By bringing their novel technologies and exposing them to a curated selection of TMC’s expert network, startups receive support and evaluation to build, scale, and expand in the US market."

Two of the cohort's specialties include cardiovascular and oncology — two of TMC's strongest areas of expertise — with solutions ranging from surgical devices to AI-enabled risk stratification and hospital efficiency.

Innovate UK is the country's national innovation agency dedicated to supporting business-led innovation in all sectors.

“The United Kingdom is fully committed to improving global healthcare through scientific collaboration," says His Majesty’s Consul General in Texas Richard Hyde in the release. "Through the expansion of the TMC UK BioBridge and in partnership with Innovate UK, this programme will help to expose the brightest and best British companies to the world’s largest medical city. Our companies will collaborate and grow as they work to develop cutting edge technology. The partnership between the UK Government and TMC demonstrates that international collaboration can drive both economic growth and improvement to quality of life.”

The 16 companies making up the inaugural cohort are as follows, according to TMC.

  • AINOSTICS aims to revolutionize the treatment and prevention of neurological conditions, such as dementia, by developing innovative AI-enabled solutions that draw novel insights from routinely acquired non-invasive medical scans to deliver accurate diagnosis and outcome prediction, and in turn facilitate personalized care and timely access to disease-modifying treatments for patients.
  • Alvie is a blended human plus AI-enabled digital solution providing personalised pre and rehabilitation coaching and supportive care for cancer and surgery. Alvie's technology combines data profiling, risk-stratification and tailored prescriptions of health and well-being with curated educational content, targeted behaviour change coaching and expert support through chat messaging and virtual consultations.
  • C the Signs™ is a validated AI cancer prediction platform, which can identify patients at risk of cancer at the earliest and most curable stage of the disease. Used by healthcare professionals, C the Signs can identify which tumor type a patient is at risk of and recommend the most appropriate next step in less than 30 seconds. The platform has detected over 10,000 patients with cancer, with over 50 different types of cancer diagnosed, and with a sensitivity of >98% for cancer.
  • At PEP Health, We believe all patients deserve the best care possible. Our cutting-edge machine-learning technology enables healthcare organisations, regulators, and insurers the real-time, actionable insights they need to have a direct and dramatic impact on patient experiences.
  • PreciousMD improves the lives of lung-cancer and other lung-related illnesses patients worldwide by enabling imaging-based diagnostics needed for personalized treatment pathways.
  • Ufonia is an autonomous telemedicine company, we use large language models and voice AI to increase the capacity of clinical professionals.
  • My mhealth offers digital therapeutics for a range of long-term conditions- COPD, Asthma, Diabetes and Heart Disease. Our product has been successfully deployed in the UK and India, with >100,000 users registered to date. Our solutions empower patients to self-manage their conditions, resulting in dramatic improvements in outcomes, as evidenced through multiple clinical trials and real-world evaluations.
  • At Surgery Hero, we offer a clinically backed solution that ensures whole-human support before and after surgery. We help health systems, employers and health plans cut costs without sacrificing quality of care.
  • Panakeia's software platform enables extremely rapid multi-omics profiling in minutes directly from routinely used tissue images without needing wet lab assays.
  • QV Bioelectronics are striving to deliver longer, better quality lives for brain tumour patients. Using their first-of-its-kind implantable electric field therapy device, GRACE, QV will provide effective, focal & continuous treatment without impacting patient quality of life.
  • 52 North is a med-tech company focused on improving health outcomes and health equity by reinventing care pathways. The NeutroCheck® solution is a finger-prick blood test and digital platform built to significantly improve safety and quality of life for cancer patients, by helping to identify at-home those patients who are at risk of the most fatal side-effect of chemotherapy: neutropenic sepsis.
  • Somnus is fulfilling an unmet need in global healthcare by developing real-time, point of care blood propofol monitoring. Its products will improve the care of sedated and anaesthetised patients, save money for hospitals, and facilitate a major reduction in greenhouse gas emissions.
  • ScubaTx is a breakthrough organ transplant preservation company established to solve the global unmet need for cost-efficient and longer-duration organ preservation technology. ScubaTx has developed a simple, small and affordable device which uses Persufflation to extend the preservation of organs.
  • IBEX is on a mission to help people live active, healthy and productive lives by increasing their access to early diagnosis of osteoporosis. The IBEX BH software as medical device delvers routine, automated assessment of fracture risk from routine radiology for earlier detection and more equitable treatment of osteoporosis.
  • NuVision produces products derived from donated human amniotic membrane that are used in ophthalmology to help patients with chronic, traumatic and post-surgical wounds of the eye to be treated earlier and recover more fully and more quickly. The company’s products are also used in the management of dry eye disease, a debilitating conditions that affects around 17m people in the USA.
  • Calon Cardio-Technology is on a mission to improve quality of life for patients with Left Ventricular Assist devices (LVAD) and reduce the common post operative complications associated with these implantable heart pumps. We plan to do this by introducing a completely wireless heart pump system and augment patient follow-up with built-in remote monitoring capabilities.

Trending News